Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-10.78%
↑ 88% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-91.16%
Historical baseline
PeriodValueYoY Change
2025-10.78%+85.0%
2024-71.95%+35.3%
2023-111.16%-17.6%
2022-94.55%+24.5%
2021-125.27%+14.6%
2020-146.72%-76.8%
2019-82.99%-5.6%
2018-78.61%+20.1%
2017-98.42%-